North America NGS-based RNA-sequencing Market: by Type (mRNA Sequencing, miRNA Sequencing, De novo Transcriptome Assembly, Small RNA Sequencing, Whole Transcriptome Sequencing, Targeted RNA Sequencing), Application (Diagnostics, Drug Discovery, Biomarker Discovery, Toxicogenomics, Personalized Medicine, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Resellers, Hospital Pharmacies, Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Pyrosequencing, Others), Organization Size (Small, Medium, Large) and By North America – Historical & Forecast Period (2020-2035) Comprehensive Study 2025

1. North America NGS-based RNA-sequencing Market Outlook

2. North America NGS-based RNA-sequencing Market Executive Summary

2.1. North America Market Revenue Size (USD Million) (2020-2035)

2.2. Key Trends By Segments (2020-2035)

2.3. Key Trends By North America (2020-2035)

3. North America NGS-based RNA-sequencing Market Key Vendors Analysis

3.1. NGS-based RNA-sequencing Market Regulatory Framework

3.2. NGS-based RNA-sequencing Market New Business and Ease of Doing Business Index

3.3. NGS-based RNA-sequencing Market Recent Developments

3.4. Top NGS-based RNA-sequencing Market Buyers Details By North America

3.5. Top NGS-based RNA-sequencing Market Suppliers Details By North America

3.6. Case Studies of Successful Key Ventures

3.7. Top Players Comparative Analysis

3.7.1. Country/Regions

3.8. Key Vendors

3.8.1. Top 5 NGS-based RNA-sequencing Market Vendors Pricing Analysis

3.8.2. NGS-based RNA-sequencing Market Product Benchmarking

3.8.3. NGS-based RNA-sequencing Market Future Investment Plans

3.9. NGS-based RNA-sequencing Market – Forces

3.9.1. NGS-based RNA-sequencing Market Drivers

3.9.2. NGS-based RNA-sequencing Market Restraints

3.9.3. NGS-based RNA-sequencing Market Challenges

3.9.3.1. Porter's Five Forces Analysis

3.9.3.1.1. NGS-based RNA-sequencing Market Bargaining Power of Suppliers

3.9.3.1.2. NGS-based RNA-sequencing Market Bargaining Power of Buyers

3.9.3.1.3. NGS-based RNA-sequencing Market Threat of New Entrants

3.9.3.1.4. NGS-based RNA-sequencing Market Threat of Substitutes

3.9.3.1.5. NGS-based RNA-sequencing Market Degree of Competition

4. North America NGS-based RNA-sequencing Market Revenue (USD Million) Size (2020-2035) - By Country Analysis

4.1. North America NGS-based RNA-sequencing Market Revenue (USD Million) By Country (2020-2035)

4.1.1. US

4.1.2. Canada

4.1.3. Mexico

5. North America NGS-based RNA-sequencing Market Revenue (USD Million) Size (2020-2035) - By Type

5.1. mRNA Sequencing

5.2. miRNA Sequencing

5.3. De novo Transcriptome Assembly

5.4. Small RNA Sequencing

5.5. Whole Transcriptome Sequencing

5.6. Targeted RNA Sequencing

6. North America NGS-based RNA-sequencing Market Revenue (USD Million) Size (2020-2035) - By Application

6.1. Diagnostics

6.2. Drug Discovery

6.3. Biomarker Discovery

6.4. Toxicogenomics

6.5. Personalized Medicine

6.6. Others

7. North America NGS-based RNA-sequencing Market Revenue (USD Million) Size (2020-2035) - By Technology

7.1. Sequencing by Synthesis

7.2. Ion Semiconductor Sequencing

7.3. Single-Molecule Real-Time Sequencing

7.4. Nanopore Sequencing

7.5. Pyrosequencing

7.6. Others

8. North America NGS-based RNA-sequencing Market Revenue (USD Million) Size (2020-2035) - By Distribution Channels

8.1. Direct Tenders

8.2. Retail Sales

8.3. Online Sales

8.4. Distributors & Resellers

8.5. Hospital Pharmacies

8.6. Others

9. North America NGS-based RNA-sequencing Market Revenue (USD Million) Size (2020-2035) - By Organization Size

9.1. Small

9.2. Medium

9.3. Large

10. Company Profile Analysis

10.1. Illumina Inc.

10.1.1. Vendors Overview

10.1.2. Business Portfolio

10.1.3. Geographical Portfolio

10.1.4. Customers

10.1.5. Financial Analysis

10.2. Thermo Fisher Scientific

10.3. Agilent Technologies

10.4. QIAGEN

10.5. BGI

10.6. PerkinElmer Inc.

10.7. Pacific Biosciences

10.8. F. Hoffmann-La Roche AG

10.9. Lexogen GmbH

10.10. Takara Bio Inc.

10.11. Oxford Nanopore Technologies

10.12. Arraystar Inc.

10.13. NuGEN Technologies (TECAN Group)

10.14. Eurofins Scientific

10.15. Macrogen Inc.

11. Sources Covered

11.1. Primary Sources

11.2. Secondary Sources